Ledger.Open graph →
SEC Form D · filed February 28, 2019

Guide Therapeutics, Inc

Offering
$5.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Other Technology
Location
ATLANTA, GA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

James R. Dahlman · Atlanta, GADirectorAndrew R. Perlman · Atlanta, GADirectorThomas R. Saylor · Atlanta, GAExec · Directornull InvestX Master GP1, Inc · Vancouver, British Columbia, CanadaDirectorKathleen S. Goin · Wayne, PADirectorScott H. Morenstein · Wayne, PAExec · DirectorTanguy Serra · SAN FRANCISCO, CADirectorDavid N. Bartelme · Milwaukee, WIExec · DirectorSequoya N. Borgman · Milwaukee, WIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗